Nick Leschly

2016 - bluebird bio

In 2016, Nick Leschly earned a total compensation of $4.9M as Chief Executive Officer at bluebird bio, a 56% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$309,375
Option Awards$2,929,487
Salary$500,000
Stock Awards$1,136,475
Other$5,250
Total$4,880,587

Leschly received $2.9M in option awards, accounting for 60% of the total pay in 2016.

Leschly also received $309.4K in non-equity incentive plan, $500K in salary, $1.1M in stock awards and $5.3K in other compensation.

Rankings

In 2016, Nick Leschly's compensation ranked 1,672nd out of 14,075 executives tracked by ExecPay. In other words, Leschly earned more than 88.1% of executives.

ClassificationRankingPercentile
All
1,672
out of 14,075
88th
Division
Manufacturing
566
out of 5,489
90th
Major group
Chemicals And Allied Products
160
out of 1,895
92nd
Industry group
Drugs
109
out of 1,538
93rd
Industry
Biological Products, Except Diagnostic Substances
21
out of 279
93rd
Source: SEC filing on April 21, 2017.

Leschly's colleagues

We found six more compensation records of executives who worked with Nick Leschly at bluebird bio in 2016.

2016

Susanna High

bluebird bio

Chief Operating Officer

2016

Jeffrey Walsh

bluebird bio

Chief Financial and Strategy Officer

2016

David Davidson

bluebird bio

Chief Medical Officer

2016

Philip Gregory

bluebird bio

Chief Scientific Officer

2016

Jason Cole

bluebird bio

Chief Legal Officer

2016

James DeTore

bluebird bio

Chief Financial Officer

News

In-depth

You may also like